WO2004061115A1 - PROCESS FOR PRODUCING SOLUBLE β-GLUCAN HAVING IMMUNOLOGICAL FUNCTION AND USE THEREOF - Google Patents

PROCESS FOR PRODUCING SOLUBLE β-GLUCAN HAVING IMMUNOLOGICAL FUNCTION AND USE THEREOF Download PDF

Info

Publication number
WO2004061115A1
WO2004061115A1 PCT/JP2003/016979 JP0316979W WO2004061115A1 WO 2004061115 A1 WO2004061115 A1 WO 2004061115A1 JP 0316979 W JP0316979 W JP 0316979W WO 2004061115 A1 WO2004061115 A1 WO 2004061115A1
Authority
WO
WIPO (PCT)
Prior art keywords
glucan
yeast
soluble
skin
acid
Prior art date
Application number
PCT/JP2003/016979
Other languages
French (fr)
Japanese (ja)
Inventor
Shu Uemura
Teruhisa Kaneko
Chihiro Kaise
Robert Nakamura
John Vercellotti
Sharon Vercellotti
Original Assignee
Immudyne Japan Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immudyne Japan Inc. filed Critical Immudyne Japan Inc.
Publication of WO2004061115A1 publication Critical patent/WO2004061115A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/04Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds

Definitions

  • the present invention relates to a method of soluble-dulcan having a boat function and its use, and more particularly to a skin cosmetic having an excellent anti-aging function for skin and an S method of soluble / 3-glucan having an immune function suitable for use in the skin cosmetic.
  • Glucan is a polysaccharide having glucose as a clean position.
  • ⁇ - (1, 6) branched) 3- (1, 3) dulcan has been shown to enhance immune function and cholesterol-lowering ability.
  • Yeast combines at least three kinds of; 3-Dalcan; refractory 3-1, 3-D-Dalcan, rod-shaped / 3- 1, 6- D-Dalcan and ⁇ - (1, 6) branched ] 3— (1, 3) Glucan.
  • linear—1, 3-D-glucan, linear; 3--1, 6-D-dalcan does not activate macrophages, NK cells or neutrophils, or very little. is there.
  • the iS— (1, 6) branched / 3_ (1, 3) glucan as a polysaccharide species is a fraction that binds to 3 ⁇ 41 by linking ill with glucose units and (1 ⁇ 6) 3-glycosylated linkage. Consists of buying.
  • Yeast — (1, 6) branched / 3— (1, 3) dulcan is composed of several relatively short side chains (10% or 10%) fed by ⁇ - (1 ⁇ 6) glycosylated linkages.
  • (1 ⁇ 3) / 3 glycosylated linkages are the members (90% of which are above) and are mostly composed of members.
  • dulcan poly (1,3) —3—D-darcopyranosirile (1,6) -one-D-crecopyranose.
  • beta-glucans There are a variety of different types of beta-glucans. Those members' thread! ⁇ , Change with branch type, monomer type or substituent • It produces polysaccharides that exhibit very different physical and biological properties.
  • ⁇ -1,3 / 1,6—D-Dalcan is known to activate the invertebrate immune system as well as vertebrates.
  • 6 _D—Dalcan is most effective in activating macrophages, NK cells and neutrophils.
  • Yeast-derived; 3 glucan activates the immune system by binding to specific receptors on the cell membrane surface of macrophages.
  • Activated macrophages increase the production of various cytokines as well as their phagocytic and bactericidal capabilities.
  • yeast iS glucan Once the functions of macrophages and sputum cells are reduced, they can become responsible for the many beneficial effects of yeast iS glucan. For example, it is possible to improve the resistance to infections caused by infestation of bacteria, viruses, and protozoan parasites.
  • macrophages are also considered to be bad if NK cells function. In contrast, the ability of the host can be improved.
  • / 3— 1, 3/1, 6-D-Dalcan is a side chain iS_ 1, 3/1, 6- D-glucan or i3—1, 3—D_Dalcan and i3—1, The decision to determine whether it is a mixture of 6_D—Krecans or all of these 3—Klecans is (at least 3 of these 3/3 as yeast disliked. —Creates all glucan) ⁇ Not J ability, but the solubility is getting worse due to the variability of the number of / 3-1, 6 side chains.
  • 3-1, 3/1, 6- D-glucan only activates macrophages, so it is desirable to use a high yarn stringer / 3-1, 1, 3/1, 6- D-Dalcan .
  • insoluble i3-1-1, 3/1, 6- D-glucan is difficult to formulate parenterally or topically administered crane IJ, and it is also difficult to absorb percutaneously.
  • S3 ⁇ 4i, a soluble glucan has also been studied (Japanese National Publication No. 5-503952 and Japanese National Publication No. Hei 107-107702), but it is sufficient to have a soluble release or no immune function. In addition to these disadvantages, their use is limited to the medical use of wound healing.
  • An object of the present invention is to solve the above-mentioned problems of the technique.
  • the first object of the present invention is to provide an effective method for producing soluble i3-dalton having immune function.
  • a second object of the present invention is to provide a dermatological agent that is easy to handle and has an excellent anti-aging effect on skin.
  • soluble iS-glucan having an immune function based on the use of 3-dalcanase in the process of elaborating 3-dalcan derived from yeast (soluble yeast bases 1, 3Z1, 6- D—Dalcan. Yeast and Z or yeast extract).
  • the present invention includes a soluble / 3-glucan (soluble yeast, 1, 3/1, 6-D-Dal force, yeast and Z or yeast extract) that functions. It is in skin cosmetics that make it a tree.
  • soluble ttJ and “solubility” and means that it dissolves in water at room temperature (including colloidal form) on the shelf.
  • the difficulty of shelf may be 1% by weight of the cosmetic.
  • the obtained ⁇ -glucan-containing substance is dissolved (dispersed) completely in water or colloidally at a concentration of 1% by weight at room temperature.
  • Soluble yeast that enhances immune function in 3-glucan-containing products / 3-1, 3/1, 6-D-Dalton content is 95-; L 0 0% by weight
  • This soluble yeast i3_l, 3/1, 6-D-Glylecan preferably has a content of 2500-600.
  • the koji method of the present invention is sensitive to the use of
  • the yeast that produces purified i3-Dalcan can be used.
  • live yeast cells themselves, dried yeast powders and Examples include soluble yeast extracts obtained by solubilizing, extracting and purifying yeast cells under appropriate conditions such as autolysis, hot water extraction, mi iY, and enzyme.
  • Yeasts include yeast jS-1,3 glucan, yeast 0-1,3 / 1,6-D-glucan, and genus Saccharomyces such as brewer's yeast, baker's yeast, and obtain yeast extract.
  • Physics, ⁇ ⁇ 0 ⁇ , and biochemical methods can be used to break down the crumbling fungus.
  • commercially available yeast dry powder, yeast extract is easy to handle and readily available ⁇ (J. Above fermentation yeast extract usually contains protein, lipid, m organic acid, vitamin, amino acid, Nucleic acid-related quality is included.
  • Yeasts suitable for use in the present invention are i3-1-3 glucan, ⁇ -1, 3/1, 6-D-glucan having a molecular weight of 2500 to 400,000 or less, preferably 2500 to 60,000 koji, and beer fermentation. Examples include mothers, baker's yeast, and other genus Saccharomyce s, and J is 95% or more.
  • the insoluble '1' powder is washed with water and then treated with acid.
  • the powder is treated with 3-Dalcanase.
  • the fermented rice cake moon cake is treated with acid, washed at 7K, and then treated with sodium sootate. Wash the powder and treat with / 3-Dalcanase. Centrifuge the enzyme-treated mixture and remove the enzyme-treated powder. The supernatant is filtered through a membrane with an apparent cut capacity of 100,000 daltons and separated into a high "volume and low ⁇ *. After this, the substance is filtered through a membrane with 1000 daltons ⁇ ? 4, • Precipitate ⁇ -1,3 / 1,6-D-glucan and wash with absolute alcohol before drying in a vacuum oven.
  • Soluble j8—1, 3/1, 6-D-Dalcan that immunizes immune functions is S3 ⁇ 4t from yeast or other microorganisms containing / 3—1, 3/1, 6-D-glucan as follows be able to.
  • the t process described here relates to the production of ⁇ ⁇ ⁇ * soluble that retains macrophage activation ability (immune function)) 6-1, 1, 3/1, 6- D-crecan.
  • ⁇ Solubility to machine / 3— 1, 3/1, 6— D-Dalkan cocoons are the first component of / 3-Dalcan Threads containing alkali and acid soluble / 3-1, 3/1, 6-D-glucan (composed of fermented Tsuruta cysts yeast wall)! ! Process Xiemoto. This allows for the action of the enzyme; 3-Dalkane is obtained. After this treatment, the dissolved; 8-1,3X1,6-D-Dalcan is purified by enzymatic hydrolysis with; 3-Dalcanase. Here, the impurity ⁇ -glucan is removed.
  • the fermented tubule or fermented rice bud wall does not solubilize / 3—1, 3,1,6-D—glucan; To do.
  • an alkali metal or alkaline earth metal hydroxide for example, sodium hydroxide or potassium hydroxide of 0.05 to 1 ON is preferably used.
  • This step is performed at 4 ° C to 150 ° C, but preferably at about 80 ° C.
  • the process is always ij, or under pressure, with about 15 Pascal Z1 2 rc being particularly preferred.
  • the processing time is usually 10 minutes to 48 hours, but it depends on the type of alkali ⁇ and ffi iK.
  • the powder is separated from the aqueous solution by an appropriate means such as centrifugation, etc. 1 ".
  • This alkali treatment may be repeated once or several times. Wash the mulberry cell wall once or several times, then treat with acid such as «, formic acid, acetic acid, etc.
  • ⁇ ⁇ Acidic acid of 1 ⁇ 5, usually 4. (: ⁇ 1 5 0 ° Treat with C for 15 minutes to 48 hours, especially 3% vinegar ⁇ ⁇ solute ⁇ 85 ° C, preferably for 45 minutes and extract.
  • Insoluble raw material is a suitable process Remove TT from the solution by washing with water once or several times and then re-it ⁇ using appropriate means.
  • a soluble, ⁇ ⁇ ⁇ (2500 to 60,000)] 3-1, 3/1, 6_D-glucan having a function of ⁇ 3 ⁇ 4 can be obtained.
  • the conventional S8t ⁇ method has the problem that about 16% mannose and the like and impurities (cannot show transport function)) contain 3-Dalcan.
  • Soluble yeast) 3-1, 3/1, 6-D-glucan is 9
  • the skin cosmetic of the present invention contains soluble
  • the form of the skin cosmetic of the present invention is not particularly P-armed.
  • skin care products such as emulsion, cream, chemical ffi7_K, packs, facial cleansers, massages, body cosmetics and emulsifying fans, etc.
  • Products and quasi drugs Both are water-based That's right.
  • the dosage form of cosmetics is also arbitrary. For example, it is possible to take a solubilizing emulsifier form or a ⁇ form.
  • the soluble / 3-glucan may be added in an amount of 0.001 to 1%.
  • Soluble / 3—glucan distribution * is less than 0.0 0 1%, the immune activity improvement effect unique to soluble i3_Dalcan is not exerted in 3 ⁇ 41, and when it exceeds 1%, discoloration, May affect the stability of the system, which is not desirable.
  • ingredients to be formulated as (optional) ⁇ in the skin cosmetics of the present invention include oils, powders, surface active substances, low alcohol, high liver compounds, gelling agents, UV absorbing UV scattering agents, antioxidants
  • components commonly used in ordinary cosmetics such as lh dyes, preservatives, fragrances, and cosmetic ingredients, and these can be selected and used as long as the effects of the present invention are not impaired.
  • Liposome membrane shape / 3 ⁇ 4 base material is natural or synthetic such as phosphatidylcholine, phosphatidylethanolamine, phosphatidylinositol, phosphatidylserine, phosphatidylglycerol, phosphatidic acid, lysophosphatidylcholine, sphingomyelin, egg yolk lecithin, ⁇ a lecithin Phospholipids or silicon-added phospholipids, cholesterols such as cholesterol, cholesterol alkyl esters, phytosterols, phytosterol alkyl esters, glyceglycoglycolipids, asildarcosides such as cetylgalactoside, dialkyl-type synthetic surfaces Active I4, N-acylsphingosine or its sulfate ester, N-acylsphingoglycolipid, N-higher acyl dirtathion or a mixture of tt ⁇ S or more It is below.
  • Sea extinguisher water is a natural water rich in nutrients that is low in temperature, clean, and rich in nutrients.
  • the water intake depth is 2500-0500m, preferably 3200-0400m. Since deep ocean water contains numerous minerals, it has excellent moisture retention. 3 ⁇ 4Sf is excellent in raw life, which is thought to promote penetration of ingredients contained in cosmetics into the skin.
  • the distribution of the seabed water is usually 40 to 99%, preferably 50 to 60%.
  • the preferred optional self-synthesized component will be described more specifically.
  • the fats and oils include jojoba, oil, castor oil, olive oil, oil, coconut oil, palm oil, cacao oil, mink oil, turtle oil and the like.
  • hydrocarbons examples include I paraffin, petrolatum, microcrystalline wax, and squalene.
  • waxes examples include beeswax, lanolin, carnauba wax, and candelillaro.
  • Examples of lunar fatty acids include myristic acid, palmitic acid, stearic acid, oleic acid, isostearic acid, lauric acid and the like.
  • Synthetic esters include isopropyl myristate, isopropyl palmitate, butyl oleate, myristyl myristate, octyldodecyl myristate, propylene glycol monostearate,?
  • Examples include L myristyl L, isostearyl malate, glyceryl monostearate, and distearyl dimethyl ammonium chloride.
  • Oils, hydrocarbons, waxes, lunar fatty acids, synthetic esthetics are usually combined. It is blended at a ratio of ⁇ 5 Ow / w%.
  • alcohols examples include ethanol, 1,3-butylene glycol, propylene glycol, lauryl alcohol, cetanol, stearyl alcohol, and oleyl alcohol.
  • Alcohols are usually blended at a ratio of 0 to 1 OwZw%.
  • J includes glycerin fatty acid esters, sorbitan fatty acid esters, polyoxyethylene fatty acid esters, polyoxyethylene sorbitan fatty acid esters, polyoxyethylene alkyl ethers, coconut oil fatty acid monoethanolamide , Polyoxyethylene hydrogenated castor oil, sodium lauryl sulfate, polyoxyethylene darericyl pyrostearate, sodium alkylbenzene sulfonate, polyoxyethylene stearyl ether, dialkylsulfosuccinic acid, cetylpyridinium bromide, n-o chloride Decyltrimethylammonium, monoalkyl phosphate, N-acylsulfuric acid, N-acylglutamine, sucrose fatty acid ester, polyoxyethylene sorbitan monostearate And polyoxyethylene lauryl ether sodium sulfate, polyoxyethylene and lanolin.
  • the surface activity '14 ⁇ 1 is usually added at
  • thickener examples include strong lpoxyvinyl polymer, methylpolysiloxane, dextran, strong lpoxymethylcellulose, carrageenan, and hydroxypropylmethylcellulose.
  • the thickener is usually blended at a ratio of 0 to 1 wZw%.
  • humectant examples include glycerin, propylene glycol, 1,3-butylene glycol, puffer glutamic acid, acetyl tiltamic acid, hyaluronic acid, procyanidine and the like.
  • Moisturizer is usually. It is blended at a rate of ⁇ 5 w / w%.
  • preservatives examples include benzoic acid, salicylic acid, dehydroacetic acid or salts thereof, phenols of parabenzoic acid esters, and tricky sanhalocarban.
  • the preservative is usually blended at a ratio of 0 to 0 ⁇ 3wZw%.
  • Any fragrance may be used as long as it is generally used for cosmetics.
  • pigments examples include iron oxide, titanium dioxide, acid bffi-lead, kaolin, and talc.
  • the prescription is usually blended at a rate of 0 to 1 wZw%.
  • ⁇ IJ includes: Wheat oil, Vitamin A, Vitamin B 2, Vitamin E, Ascorbile acid mono-2-magnesium or sodium phosphate, D-Pantole alcohol, Dipotassium glycyrrhizinate, Dartathione, UV absorber, Chelating agent, Examples include plant extracts and microbial metabolite Z extracts.
  • W usually 0 to 3 w / w%.
  • Yeast, yeast extract, especially yeast cell wall —Dalcan has a high texture of ⁇ mi kinetic I ', so various cells and activities related to immune enhancement such as T cells and complement system It has been reported that it has a slight biological activity, while it has a brilliant biological activity, but on the other hand, there is almost no horn
  • Skin aging prevention cosmetics act mainly on rough skin (due to seasonal changes) and skin trauma caused by temporary deterioration of skin function. Drowning due to systemic malfunction requires an improvement in the balance of the person's entire biological system.
  • the skin cosmetics containing S-Dalcan (P-P) of the present invention acts on the wrinkle system and improves the balance of the biological system from the inside of the skin function. Of course, the effect on the human body is very sensible.
  • the skin cosmetics of the present invention have been used poorly solubilizing monoglucans that could not be formulated with water-soluble and transparent dosage forms of aqueous cosmetics (for example, chemicals can be formulated, and cosmetic cosmetic dosage forms
  • aqueous cosmetics for example, chemicals can be formulated, and cosmetic cosmetic dosage forms
  • the ij ability is used regardless of the choice, and is excellent in wrinkling on the skin, and exhibits excellent skin aging prevention effects on wisteria.
  • the rate of liposomes is dramatically improved, and it becomes possible for the first time to prepare a ribosome carrying more ⁇ -dulcan.
  • the amount of iS-Dalcan on the skin ? ! Improves MS MS and gains higher skin care effects (moisturizing, acupuncture, wrinkles, skin turnover, etc.).
  • the / 3-1, 1, 3/1, 6-D-glucan powder from this concession was washed with water with stirring for 15 minutes.
  • the fermented crane was treated with 10% 3% acetone in water at 37 ° C, koji was added, heated to 85 ° C, and stirred for 45 minutes. After washing the residue with water, it was treated with 15-75% of hypochlorous acid: * sodium acid. (Preferable conditions are a 20% concentration, a temperature of 4 to 150 ° C., more preferably 50 ° C. for 15 minutes to 48 hours.)
  • the straw was washed several times.
  • the dried precipitate is further purified by chromatography (affinity, dialysis, chromatography, etc.) or by dialysis using a filter that can select various 3 ⁇ 4.
  • the result of making 3 ⁇ 4 ⁇ containing 0.05% Taleton) in the morning is 8 weeks on the face of 100 women.
  • the present test was hired specialists as the ⁇ 1 is the result of Hosohito was monitored scratch mosquito ⁇ felt how after shelf
  • the method was prepared according to a conventional method and used as an emulsion.
  • the seawater layer water used here (reverse consideration) is the water that has been treated by retreating the ocean.
  • Example 3 Soluble glucan prepared by a method according to the method of Example 1 from about 800 to 100
  • FIG. 2 shows the results of examining the skin surface condition in a replica after 8 weeks of use and examining the improvement rate. (In addition, is as shown in Example 2.)
  • emulsion containing 0.05% of soluble 'I raw klecan 1 ⁇ 2H3 ⁇ 4 approximately 5 0 0 0 0 evening lens) prepared by the method of Example 1 was prepared.
  • Fig. 3 shows the results of a tape stripping test on the condition of the stratum corneum of the skin after using it for 8 weeks in the morning and evening, and examining the improvement rate. (The prescription is as shown in Example 2.) From the results of tape stripping, keratinocyte coverage was recognized before conversion in any of the cases, but 8 weeks after use. It turned out to be almost inconspicuous, and the stratum corneum was improved to a healthy state.
  • i3 ⁇ 4T indicates delamination of the stratum corneum, indicating that the skin condition is not healthy.
  • Soluble dulcan prepared by a method according to the method of Example 1 about 5 0 0 0 0 dart was prepared on the upper arm of 10 females for 4 weeks, and the skin turnover state was tested by the tape stripping method.
  • Figure 4 shows the results of the improvement rate. (The prescription is as shown in Example 2.)
  • the stratum corneum was peeled off in the state where the skin was previously roughened (color).
  • Fig. 1 is a graph showing the wrinkle improvement results (visually) of Example 3.
  • Fig. 2 is a graph showing the wrinkle improvement results (crane by replica) of Example 4.
  • FIG. 3 is a graph showing the improvement results of the stratum corneum in Example 5.
  • FIG. 4 is a draaf showing the improvement result of Kakuda rice cyst of Example 6.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

It is intended to provide a process for effectively producing a soluble β-glucan having an immunological function and a skin cosmetic showing a remarkably excellent effect of preventing skin aging. A soluble β-glucan having an immunological function (soluble yeast beta 1,3/1,6-D-glucan, yeast and/or yeast extract) is produced with the use of β-glucanase and then employed in skin cosmetics.

Description

明 細 書 免疫機能を^ る可溶性 )3—クレカンの 法及び用途  Description Soluble with immune function) 3-Klecan method and application
棚分野 Shelf field
本発明は艇機能を衬る可溶性 —ダルカンの 方法及びその用途に関し、特に優れ た皮膚老化防止機能をもつ皮膚化粧料とそれに用いるに適する免疫機能を有する可溶性 /3 一グルカンの S 方法に関する。  The present invention relates to a method of soluble-dulcan having a boat function and its use, and more particularly to a skin cosmetic having an excellent anti-aging function for skin and an S method of soluble / 3-glucan having an immune function suitable for use in the skin cosmetic.
背景謹 Background
グルカンはグルコースを構鮮位とする多糖類である。 β— (1, 6)分岐した )3— (1, 3) ダルカン 。ン酵 §^他の酵母種、 キノコ、 植物およぴ 々のバクテリア、 ; 類や藻 類 (Chemi s t ry and B i o l ogy o f (1→3) — β-G 1 u c an s, B. A. S t one and A. E. C l a rke, 1992, La Tr obe U n i v e r s i t y P r e s s, Au s t o r a l i aで総説されている)から抽出され る天然に る多糖類種である。 β- (1, 6) 分岐した) 3— (1, 3) ダルカンは免疫 碰およびコレステロール低下能を ί鹏することが示されてきた。酵母は少なくとも 3種の ;3—ダルカンを合 る;難員状 3— 1, 3—D—ダルカン、 麵状 /3— 1, 6— D—ダル カンそして β— (1, 6) 分岐した ]3— (1, 3) グルカン。 しかし、 直鎖状 — 1, 3- D—グルカン、 直鎖状 ;3— 1, 6— D—ダルカンはマクロファ一ジや NK細胞あるいは好中 球を活性化しないか、 するとしても極僅かである。  Glucan is a polysaccharide having glucose as a clean position. β— (1, 6) Branched) 3— (1, 3) Dalkan. Fermentation § ^ Other yeast species, mushrooms, plants and various bacteria; algae and algae (Chemi stry and Biol ogy of (1 → 3) — β-G 1 uc an s, BA St one and AE Clarke, 1992, reviewed by La Trobese University Press, Australia). β- (1, 6) branched) 3- (1, 3) dulcan has been shown to enhance immune function and cholesterol-lowering ability. Yeast combines at least three kinds of; 3-Dalcan; refractory 3-1, 3-D-Dalcan, rod-shaped / 3- 1, 6- D-Dalcan and β- (1, 6) branched ] 3— (1, 3) Glucan. However, linear—1, 3-D-glucan, linear; 3--1, 6-D-dalcan does not activate macrophages, NK cells or neutrophils, or very little. is there.
多糖類種としての iS— (1, 6) 分岐した /3_ (1, 3) グルカンは、 グルコースを単位 とした連結 illと (1→6) 3配糖体化リンケージにより ¾1に結合する分險買から成る。 酵母 — (1, 6) 分岐した /3— (1, 3) ダルカンは、 β— (1→6) 配糖体化リンケ一 ジで糸給した数個の比較的短い側鎖(10%あるいはそ; Π¾下) をィ腊する (1→3) /3配 糖体化リンケージで糸給したダルコ一スを単位とした 員(90%ぁるぃはそ 上)から 成るのがほとんどである;このダルカンの化学名はポリ一 (1, 3) — 3— D—ダルコピラ ノシリレー (1, 6) 一 一D—クレコピラノースである。 ベータグルカンには種々の異なつ たタイプがある。それら 員の糸!^、 分岐タイプ、 モノマ一タイプあるいは置換基で変化 •し、 それはきわめて異なる物理的、 生物学的特性を示す多糖類を生み出す。 The iS— (1, 6) branched / 3_ (1, 3) glucan as a polysaccharide species is a fraction that binds to ¾1 by linking ill with glucose units and (1 → 6) 3-glycosylated linkage. Consists of buying. Yeast — (1, 6) branched / 3— (1, 3) dulcan is composed of several relatively short side chains (10% or 10%) fed by β- (1 → 6) glycosylated linkages. (1 → 3) / 3 glycosylated linkages are the members (90% of which are above) and are mostly composed of members. The chemical name of this dulcan is poly (1,3) —3—D-darcopyranosirile (1,6) -one-D-crecopyranose. There are a variety of different types of beta-glucans. Those members' thread! ^, Change with branch type, monomer type or substituent • It produces polysaccharides that exhibit very different physical and biological properties.
β— 1, 3/1, 6— D—ダルカンは、 脊椎動物と同様に無脊椎動物の免疫システムを活 性化することが知られているが、 酵母由来の i3— 1, 3/1, 6 _D—ダルカンがマクロフ ァージ、 NK細胞及 ϋ¾子中球を活性化する上で最も効果的である。酵母由来の ;3グルカンは マクロファージの細胞膜表面にある特異的受容体に結合することで免疫システムを活性化 する。活性化されたマクロファージはそれらの食細胞能や殺菌能と同様に様々なサイトカイ ンの生産を増加させる。 マクロファージゃ ΝΚ細胞の機能が羅されると、それらは酵母 iS グルカンの多数の有益な効果を司るようになれる。 たとえば、 細菌、 ビールス、 カビゃ原虫 類の寄生による感染症への抵抗力を向上させることが"!?きる。 さらに、 マクロファージゃ N K細胞の機能が腿されると、それらは悪 'f»慮に対して宿主の關卩能を向上させることが できる。  β-1,3 / 1,6—D-Dalcan is known to activate the invertebrate immune system as well as vertebrates. 6 _D—Dalcan is most effective in activating macrophages, NK cells and neutrophils. Yeast-derived; 3 glucan activates the immune system by binding to specific receptors on the cell membrane surface of macrophages. Activated macrophages increase the production of various cytokines as well as their phagocytic and bactericidal capabilities. Once the functions of macrophages and sputum cells are reduced, they can become responsible for the many beneficial effects of yeast iS glucan. For example, it is possible to improve the resistance to infections caused by infestation of bacteria, viruses, and protozoan parasites. In addition, macrophages are also considered to be bad if NK cells function. In contrast, the ability of the host can be improved.
パン酵母あるいはビール酵母 (ビール酵母菌)、 同様に他の酵母から単離された3—1, 3/1, 6—D—グルカンは不溶性である。 さらには /3— 1, 3/1, 6—D—ダルカンが 側鎖を持った iS_ 1, 3/1, 6— D—グルカンなのか i3—l, 3— D_ダルカンと i3— 1, 6 _D—クレカンの混合物なのか、 あるいはすベてのそれら 3種の 3—クレカンの混合物な のかどう力ゝを決 ¾ ることは、 (酵母は嫌 3したように少なくともそれら 3種の /3—グルカ ンすべてを作りだす) ^ J能ではないが、 /3 - 1, 6側鎖の数の変異性により極端に溶解性 が悪くなつている。分岐の ]3— 1, 3/1, 6— D—グルカンのみがマクロファ一ジを活性 化するので、 糸艘の高い /3— 1, 3/1, 6— D—ダルカンを用いることが望ましい。一方、 不溶性 i3— 1, 3/1, 6— D—グルカンは非経口や局所投与鶴 IJへ処方組みすることは難 しぐ また、 経皮吸収もされにくいため、 その効果を発揮させるには処方上の制限がある。 可溶性グルカンの S¾iについても検討がなされている(特表平 5— 503952号公及び 特表平 6— 107702号公報)が、 可溶性の離カ坏十分であったり免疫機能がないカ坏 十分である等の欠点をもっと共に、 その用途も創傷治歸轉の医薬用途に限られている。 一方、雞溶性3—グルカンを配合した皮膚化粧料は知られており、本出願人も既に驗し ている (特願 2000— 390953号)。 しかし徹知られた化粧料用の膽容性 i3—ダル カンは配合が困難であるだけでなく皮膚老化防 lh¾¾ (荒れ肌改^ ¾果、 角質改皆効果、 タ —ンオーバ一避を正常化する効果、 しわ防 ¾果) が必ずしも十分ではなぐ 配^^の取 り扱いが容易で優れた皮膚老化防止効果をもつ皮膚化粧料の開発が く求められている。 発明の目的 Baker's yeast or brewer's yeast (brewer's yeast) as well as 3-1, 3/1, 6-D-glucan isolated from other yeasts are insoluble. In addition, / 3— 1, 3/1, 6-D-Dalcan is a side chain iS_ 1, 3/1, 6- D-glucan or i3—1, 3—D_Dalcan and i3—1, The decision to determine whether it is a mixture of 6_D—Krecans or all of these 3—Klecans is (at least 3 of these 3/3 as yeast disliked. —Creates all glucan) ^ Not J ability, but the solubility is getting worse due to the variability of the number of / 3-1, 6 side chains. Branched] 3-1, 3/1, 6- D-glucan only activates macrophages, so it is desirable to use a high yarn stringer / 3-1, 1, 3/1, 6- D-Dalcan . On the other hand, insoluble i3-1-1, 3/1, 6- D-glucan is difficult to formulate parenterally or topically administered crane IJ, and it is also difficult to absorb percutaneously. There are prescription restrictions. S¾i, a soluble glucan, has also been studied (Japanese National Publication No. 5-503952 and Japanese National Publication No. Hei 107-107702), but it is sufficient to have a soluble release or no immune function. In addition to these disadvantages, their use is limited to the medical use of wound healing. On the other hand, skin cosmetics containing soluble 3-glucan are known and the present applicant has already hesitated (Japanese Patent Application No. 2000-390953). However, the well-known cosmetic tolerability i3—Dalkan is not only difficult to formulate, but also prevents skin aging lh¾¾ (rough skin modification, keratin modification effect, There is a strong demand for the development of skin cosmetics that are easy to handle and have an excellent anti-aging effect on skin. Object of the invention
本発明の目的は上記した 術の問題点を解決することにある。  An object of the present invention is to solve the above-mentioned problems of the technique.
本発明の第 1の目的は免疫機能を有する可溶性 i3—ダル力ンの効果的な製造方法を提供 することにある。  The first object of the present invention is to provide an effective method for producing soluble i3-dalton having immune function.
本発明の第 2の目的は取り扱いが容易にして ¾に優れた皮膚老化防 ¾果をもつ皮膚 ィ匕 ffi料を提供することにある。  A second object of the present invention is to provide a dermatological agent that is easy to handle and has an excellent anti-aging effect on skin.
発明の開示 Disclosure of the invention
本発明は、第 1に、酵母由来の3—ダルカンの精纏程で3—ダルカナーゼを用いること を !敷とする免疫機能を る可溶性 iS—グルカン (可溶性酵母べ一夕 1 , 3Z1 , 6 -D —ダルカン.酵母及び Z又は酵母抽出物) の $¾ 方法にある。  In the present invention, firstly, soluble iS-glucan having an immune function based on the use of 3-dalcanase in the process of elaborating 3-dalcan derived from yeast (soluble yeast bases 1, 3Z1, 6- D—Dalcan. Yeast and Z or yeast extract).
本発明は、 第 2に、 機能を^ Tる可溶性 /3—グルカン (可溶性酵母べ一夕 1, 3/ 1 , 6— D—ダル力ン .酵母及び Z又は酵母抽出物) を含^ Tることを樹敷とする皮膚化粧料に ある。  Secondly, the present invention includes a soluble / 3-glucan (soluble yeast, 1, 3/1, 6-D-Dal force, yeast and Z or yeast extract) that functions. It is in skin cosmetics that make it a tree.
発明の実施の形 ϋ DETAILED DESCRIPTION OF THE INVENTION
本発明において「可溶 ttJと¾溶性と同義であり、棚 において室温の水に溶解(コ ロイド状も含む)することをいう。棚難は化粧料の齢 1重量%でよい。 換討れば Ϊ又 得した β—グルカン含有物が室温で 1重量%濃度で水に完全に又はコロイド状に安定に溶 解 (分散) するもの〖鉢発明にいう 「可溶 ffij の規定に包含される。典型的には取得した] 3 ーグルカン含有物中における免疫機能を衬る可溶性酵母 /3—1, 3/ 1 , 6— D—ダル力 ンの含有量が 9 5〜; L 0 0重量%のものが包含される。 この可溶性酵母 i3 _ l , 3/ 1 , 6 —D—グリレカンの分 は 2 5 0 0〜6 0 0 0 0であることが好ましい。  In the present invention, it is synonymous with “soluble ttJ” and “solubility” and means that it dissolves in water at room temperature (including colloidal form) on the shelf. The difficulty of shelf may be 1% by weight of the cosmetic. For example, the obtained β-glucan-containing substance is dissolved (dispersed) completely in water or colloidally at a concentration of 1% by weight at room temperature. [Typically obtained] Soluble yeast that enhances immune function in 3-glucan-containing products / 3-1, 3/1, 6-D-Dalton content is 95-; L 0 0% by weight This soluble yeast i3_l, 3/1, 6-D-Glylecan preferably has a content of 2500-600.
本発明の纖方法は酵母由来の纖(不溶' 14) 3—グルカンを精製する過程で加水響 素として |3—ダルカナ一ゼを用いることに繊を^ る。  The koji method of the present invention is sensitive to the use of | 3-Dalkanase as a hydrolysin in the process of purifying yeast-derived koji (insoluble '14) 3-glucan.
精製 i3—ダルカンをもたらす酵母(酵母抽出物も含む) は 口られた麓のものを用い ることができる。 具体的には、 酵母生菌体そのもの、 酵母菌体を乾燥粉末化したものおよび 酵母菌体を自己消化、 熱水抽出、 mi iY , 酵素 等の適当な条件下で可溶化、 抽出、 精製等を行つた可溶性の酵母エキス等が含まれる。 The yeast (including yeast extract) that produces purified i3-Dalcan can be used. Specifically, live yeast cells themselves, dried yeast powders and Examples include soluble yeast extracts obtained by solubilizing, extracting and purifying yeast cells under appropriate conditions such as autolysis, hot water extraction, mi iY, and enzyme.
酵母には、 酵母 jS— 1, 3グルカン、 酵母 0—1, 3/1, 6—D—グルカン、 ならびに ビール酵母、 パン酵母等 S acchar omy c e s属その他があり、 また酵母抽出物を得 る 、 鶴な菌体の破藝理として物理学的、 ィ匕^ 0勺、 生化学的方法が删されうる。 本 発明では、 原料となる菌イ極、 起源や抽出方法、 精嫩、 処理藤の S 法を問わず、 ί& に選択、 棚できる。 中でも、 市販されている酵母の乾燥粉末、 酵母エキスが扱いやすぐ また容易に入手でき蟒 (Jである。 上記の酵 酵母抽出物には、 通常蛋白質、 脂質、 m 有機酸、 ビタミン、 アミノ酸、 核酸関»!質 ^用な^が含まれている。  Yeasts include yeast jS-1,3 glucan, yeast 0-1,3 / 1,6-D-glucan, and genus Saccharomyces such as brewer's yeast, baker's yeast, and obtain yeast extract. Physics, 匕 ^ 0 勺, and biochemical methods can be used to break down the crumbling fungus. In the present invention, it is possible to select and shelf regardless of the fungus used as a raw material, the origin, the extraction method, the koji, or the S method of treated wisteria. Among them, commercially available yeast dry powder, yeast extract is easy to handle and readily available 蟒 (J. Above fermentation yeast extract usually contains protein, lipid, m organic acid, vitamin, amino acid, Nucleic acid-related quality is included.
本発明で用いるに適した酵母は分子量 2500〜40万以下、好ましくは 2500〜6万 禾號からなる i3— 1, 3グルカン、 β— 1, 3/1, 6—D—グルカン、 ならびにビール酵 母、 パン酵母等 S accharomyce s属その他が挙げられ、 その J は 95 %以上の ものである。  Yeasts suitable for use in the present invention are i3-1-3 glucan, β-1, 3/1, 6-D-glucan having a molecular weight of 2500 to 400,000 or less, preferably 2500 to 60,000 koji, and beer fermentation. Examples include mothers, baker's yeast, and other genus Saccharomyce s, and J is 95% or more.
以下に、 本発明の^ i方法の典型例について説明する。  A typical example of the i method of the present invention will be described below.
酵働田胞を塩基性下で処理した後、 不溶' 1 ' 紛を水で洗浄し、 次いで酸で処理する。 さら にその歹紛を ]3—ダルカナーゼで処理する。 別法として、 酵溺田月纖を酸で処理し、 7Kで洗 浄し、 次いで麵纏酸ナトリウムで処理する。その歹紛を洗浄した後、 /3—ダルカナーゼ で処理する。酵素処理混合物を遠心分離し、 その酵素処理歹紛は麟する。上澄みを 100, 000ダルトンの見かけの^ ^量カツト能を持つ膜を通してろ過し、高 "量と低^ *に 分 る。 この後、 »物を 1000ダルトンの ^?4を持つ膜を通してろ過、 ?廳し、 β — 1, 3/1, 6-D-グルカンを析出させ、 真空オーブン等での乾燥前に無水アルコール で洗浄する。  After the fermented starch is treated under basic conditions, the insoluble '1' powder is washed with water and then treated with acid. In addition, the powder is treated with 3-Dalcanase. Alternatively, the fermented rice cake moon cake is treated with acid, washed at 7K, and then treated with sodium sootate. Wash the powder and treat with / 3-Dalcanase. Centrifuge the enzyme-treated mixture and remove the enzyme-treated powder. The supernatant is filtered through a membrane with an apparent cut capacity of 100,000 daltons and separated into a high "volume and low ^ *. After this, the substance is filtered through a membrane with 1000 daltons ^? 4, • Precipitate β-1,3 / 1,6-D-glucan and wash with absolute alcohol before drying in a vacuum oven.
免疫機能を¾1"る可溶性 j8— 1, 3/1, 6— D—ダルカンは酵母あるいは /3— 1, 3/ 1 , 6-D-グルカンを含む他の微生物から次のようにして S¾tすることができる。  Soluble j8—1, 3/1, 6-D-Dalcan that immunizes immune functions is S¾t from yeast or other microorganisms containing / 3—1, 3/1, 6-D-glucan as follows be able to.
ここで述べる^ t工程は、 マクロファージの活性化能(免疫機能) を保持する ίδ^ΐ*可 溶性 )6— 1, 3/1, 6— D—クレカンの製造に関するものである。:^機 を する可溶 性 /3— 1, 3/1, 6— D—ダルカンの纖は、 まず /3—ダルカン の成分を するた めアルカリと酸性溶 /3— 1, 3/1, 6— D—グルカンを含 る(酵鶴田胞ゃ酵母 壁から成る)糸!!謝本を処理する。 これにより酵素の作用に禾拥できる ;3—ダルカンが得られ る。 この処理の後、 溶解した ;8— 1, 3X1, 6— D—ダルカンの ;3—ダルカナーゼによる 酵素加水^^と精製を行う。 ここで不純物の β―グルカンが除かれる。 The t process described here relates to the production of ίδ ^ ΐ * soluble that retains macrophage activation ability (immune function)) 6-1, 1, 3/1, 6- D-crecan. : ^ Solubility to machine / 3— 1, 3/1, 6— D-Dalkan cocoons are the first component of / 3-Dalcan Threads containing alkali and acid soluble / 3-1, 3/1, 6-D-glucan (composed of fermented Tsuruta cysts yeast wall)! ! Process Xiemoto. This allows for the action of the enzyme; 3-Dalkane is obtained. After this treatment, the dissolved; 8-1,3X1,6-D-Dalcan is purified by enzymatic hydrolysis with; 3-Dalcanase. Here, the impurity β-glucan is removed.
上記の製造工程をまとめると次のようになる。  The above manufacturing process is summarized as follows.
a. 酵働田胞あるいは酵纖田胞壁が /3— 1, 3,1, 6—D—グルカンを可溶化せず、 細胞 のアル力リ可溶性成分を可溶化する加温下に塩 理する。  a. The fermented tubule or fermented rice bud wall does not solubilize / 3—1, 3,1,6-D—glucan; To do.
b. 7洗後、 β - 1' 3/1, 6— D—ダルカンを含 ¾ る歹纷を加温下に酸処理する。 別の方法としては、 b. After washing 7, acid-treat the soot containing β-1 ′ 3/1, 6-D-Dalcan under heating. Alternatively,
a-1. 酵删膽を醒理する。  a-1.
b-1. 水洗後、 β-1, 3/1, 6— D—グレカンを含 る歹紛を、 酸ナト リウムで処理する。  b-1. After washing with water, treat the powder containing β-1, 3/1, 6-D-grecan with sodium acid.
c τΚ洗後、 bあるいは b—l中の歹紛を で酵母由来の —ダルカナ一ゼにより加 水 する。 c After washing with τ, add the powder in b or b-l with dulkanase from yeast.
d. 混合物を遠心分離し、 歹紛は藤する。 d. Centrifuge the mixture and strain the powder.
e. 酵素^ »された /3—グルカンを含 ¾ る上澄みを、見かけの ¾¾ット能たとえば 1 00, 000ダルトンを持つ膜を通して ろ過する。次いで、 翻勿中の) 3—ダルカンを 以下の gのように処理し、 コロイド状 一 1, 3/1, 6— D—ダルカンを得る。 e. Filter the supernatant containing the enzyme / 3—glucan through a membrane with an apparent ¾¾t capacity, eg, 100,000 daltons. Next, treat the 3-dalcan (under control) as in g below to obtain colloidal 1, 1, 3/1, 6-D-dalcan.
f · 溶出液を見かけの^ *カツト能たとえば 1000ダルトンを持つ膜を通して 過 する。 そして、 ィ; ^勿を以下の gように処理し、 可溶性 )3—ダルカンを得る。  f · Pass the eluate through a membrane with an apparent cutting ability, eg 1000 Daltons. And ii; ^ Sorry is treated as follows to obtain soluble) 3-Dalcan.
g . eから ίまでの を?雄し、 100 %ェタノールでけん濁する。 g. Add to e from ί and suspend in 100% ethanol.
h. 物をエタノールで洗浄し、 慰喿する。 もし必要なら、 異なる ίΗ¾カット能を持つ H の膜を通して ろ過することで、 あるいはクロマトグラフィーによりさらに精製、 分 画することもできる。 h. Wash items with ethanol and comfort. If necessary, it can be further purified and fractionated by filtration through a membrane of H with a different cut capacity or by chromatography.
酵溺田胞あるいは酵扇田胞壁全体を、 アルカリ裔夜に分散し加熱する。その際のアルカリ τΚ溶液としては、 アルカリ金属又はアルカリ土類金属の水酸化物、 たとえば、 水酸化ナトリ ゥムゃ水酸化カリウムの 0. 05〜1 ONの水赚が好ましく用いられる。この工程は、 4°C 〜150°Cの で行われるが、好ましくは約 80°Cで行われる。 また、 その工程雄常の i j , あるいは加圧下に行われるが、 約 1 5パスカル Z1 2 rcが特に好ましい。処理時 間は、 通常 1 0分〜 4 8時間であるが、 アルカリ^^ 、 ffi iK本の種類にも依^ る。 一度アルカリ処理を行った後に、歹紛を適切な手段、 たとえば 理ゃ遠心分離など によって、 水溶 ら分寫 1 "る。 このアルカリ処理は、 1回でも数回繰り返してもよい。 歹紛又は酵碰田胞壁を 1回ないし数回水洗浄し、 次いで、 «、 ギ酸、 酢酸などの酸によ つて処理する。 ρ Η= 1〜5の酸性^ 、 通常 4。 (:〜 1 5 0°Cで、 1 5分から 4 8時間処 理する。特に 3 %の酢酉 ΙτΚ溶^ 8 5°C、 4 5分間処理を行い、 抽出することが好ましい。 不溶性の原料 ーグルカン) は、 適切な工程により、 溶液から分 TTる。歹纷は、 水で 1 回ないし数回洗い、 適切な手段で再 it ^離を行う。 Disperse the whole fermented rice cake or fermented fan rice cell wall in the alkaline night and heat it. As the alkali τΚ solution at that time, an alkali metal or alkaline earth metal hydroxide, for example, sodium hydroxide or potassium hydroxide of 0.05 to 1 ON is preferably used. This step is performed at 4 ° C to 150 ° C, but preferably at about 80 ° C. Also, the process is always ij, or under pressure, with about 15 Pascal Z1 2 rc being particularly preferred. The processing time is usually 10 minutes to 48 hours, but it depends on the type of alkali ^^ and ffi iK. Once the alkali treatment is performed, the powder is separated from the aqueous solution by an appropriate means such as centrifugation, etc. 1 ". This alkali treatment may be repeated once or several times. Wash the mulberry cell wall once or several times, then treat with acid such as «, formic acid, acetic acid, etc. ρ Η = Acidic acid of 1 ~ 5, usually 4. (: ~ 1 5 0 ° Treat with C for 15 minutes to 48 hours, especially 3% vinegar 酉 τΚsolute ^ 85 ° C, preferably for 45 minutes and extract.Insoluble raw material (glucan) is a suitable process Remove TT from the solution by washing with water once or several times and then re-it ^ using appropriate means.
次いで残物を 1 5〜 7 5 %の次亜塩素酸ナトリゥムにより 4 ° (:〜 1 5 0 °Cで 1 5分から The residue is then washed with 15-75% sodium hypochlorite at 4 ° (from 15 ° C to 15 ° C for 15 minutes).
4 8分間処理して取り出す。 残分は、 水で 1回ないし数回洗浄する。 4 Remove for 8 minutes. Wash the remainder with water once or several times.
歹紛を β一ダルカナ一ゼ,素で通常 1 0 °C〜 8 0 で 1 5分から 4 8時間処理する。 この 条件は、 ^^と激夜优態、 酵素 ¾に依 fる。 可溶性酵素消化分は、遠心分離や ¾¾1など の適切な方法により非消化原料から分 ITTる。可溶性消ィ [^料は!^議ゃク口マトグラフ ィ—、 讀縛の方法により分画する。  Treat the powder with β-Dalkanase, usually from 10 ° C to 80 ° C for 15 minutes to 48 hours. This condition depends on ^^, extreme night advantage, and enzyme ¾. The soluble enzyme digestion is separated from the undigested material by an appropriate method such as centrifugation or ¾¾1. Soluble extinguishment [^ Fee! ^ Conclusions, fractionation by binding method.
かくして^ ¾機能を る可溶性、 ίδ^ΐΜ (2 5 0 0〜6万) の ]3— 1, 3/ 1 , 6 _ D—グルカンを取得することができる。 これまでの S8t^法では約 1 6 %のマンノース等や 不純物となりうる (搬機能を示さない) )3—ダルカンが含有されるという問題点を有して いたが、、 本発明により免疫機能を る可溶性酵母) 3— 1 , 3/ 1 , 6 - D—グルカンが 9 Thus, a soluble, ίδ ^ ΐΜ (2500 to 60,000)] 3-1, 3/1, 6_D-glucan having a function of ^ ¾ can be obtained. The conventional S8t ^ method has the problem that about 16% mannose and the like and impurities (cannot show transport function)) contain 3-Dalcan. Soluble yeast) 3-1, 3/1, 6-D-glucan is 9
5 %以上という高糸艘で含 る可溶性 ;3—グルカンを取得すること力河能となった。 It became a powerful ability to obtain soluble; 3-glucan containing 5% or more of high thread cake.
次に本発明の皮膚化粧料について説明する。  Next, the skin cosmetic of the present invention will be described.
本発明の皮膚化粧料は、 可溶性 |3—ダルカン (酵母及び Z又は酵母抽出物) を必須 分と して含有し、 好ましくはリポゾ一 »として及び Z又は海 ?罙層水、 皮膚化粧料に常用 される成分を配合し、 調製される。  The skin cosmetic of the present invention contains soluble | 3-Dalcan (yeast and Z or yeast extract) as an essential component, preferably as a lipozo »and Z or sea? It is prepared by blending ingredients commonly used in soaking water and skin cosmetics.
本発明の皮膚化粧料は、 その形態は、 特に P腕されず、 例えば、 乳液、 クリーム、 化 ffi7_K、 パック、洗顔料、 マッサージ料などのスキンケア製品ならびにボディ用化粧料や乳化ファン デ一シヨン等の製品、 医薬部外品等を挙げること力 きる。 いずれも水性であることが好ま しい。化粧料の剤形も任意であり、例えば、 可溶化系乳化剤形あるいは分 βの剤形をとる ことカ^きる。 The form of the skin cosmetic of the present invention is not particularly P-armed. For example, skin care products such as emulsion, cream, chemical ffi7_K, packs, facial cleansers, massages, body cosmetics and emulsifying fans, etc. Products and quasi drugs. Both are water-based That's right. The dosage form of cosmetics is also arbitrary. For example, it is possible to take a solubilizing emulsifier form or a β form.
本発明の皮膚化粧料において、可溶性 /3 -グルカンは 0. 0 0 1〜1 %配合すればよい。 可溶性 /3—グルカンの配^ *が 0. 0 0 1 %未満では、 可溶性 i3 _ダルカン特有の免疫活性 向上効果が有 ¾1に発揮されず、 また 1 %を越えて酉己合すると、 変色、 などの安定性に影 響を及ぼす可能性があり、 好ましくない。  In the skin cosmetic of the present invention, the soluble / 3-glucan may be added in an amount of 0.001 to 1%. Soluble / 3—glucan distribution * is less than 0.0 0 1%, the immune activity improvement effect unique to soluble i3_Dalcan is not exerted in ¾1, and when it exceeds 1%, discoloration, May affect the stability of the system, which is not desirable.
本発明の皮膚化粧料に任意)^として配合される成分の例としては、 油剤、 粉体、 界面活 '隐 精 低級アルコール、 高肝化合物、 ゲル化剤、 紫外線吸籠 紫外線散乱剤、 酸化防 lh¾ 色素、 防腐剤、 香料、 美容成分等の通常の化粧料に常用されている成分があり、 これらを本発明の効果を損なわない範囲で MS択して用いることができる。  Examples of ingredients to be formulated as (optional) ^ in the skin cosmetics of the present invention include oils, powders, surface active substances, low alcohol, high liver compounds, gelling agents, UV absorbing UV scattering agents, antioxidants There are components commonly used in ordinary cosmetics such as lh dyes, preservatives, fragrances, and cosmetic ingredients, and these can be selected and used as long as the effects of the present invention are not impaired.
リポソ一ムの膜形 /¾基材としては、 ホスファチジルコリン、 ホスファチジルエタノールァ ミン、 ホスファチジルイノシトール、 ホスファチジルセリン、 ホスファチジルグリセロール、 ホスファチジン酸、 リゾホスファチジルコリン、 スフインゴミエリン、 卵黄レシチン、 ^ a レシチン等の天然もしくは合成のリン脂質また〖脉素添加リン脂質、 コレステロール類、 た とえばコレステロール、 コレステロールのアルキルエステル、 フィトステロール、 フィトス テロールのアルキルエステル、 グリセ口糖脂質、 セチルガラクトサイドの如きァシルダルコ シド、 ジァルキル型合赫面活' I4 、 N—ァシルースフインゴシン又はその硫酸エステル、 N—ァシルスフィンゴ糖脂質、 N—高級ァシルダルタチオンの一種また tt^S以上の混合物 が挙げられる。 この他、 リボソームの安定化もしくは相転移 の改善のために飾アルコ —ル、 高級アルコール、 高,徹旨肪酸等を必要に応じて配合できる。  Liposome membrane shape / ¾ base material is natural or synthetic such as phosphatidylcholine, phosphatidylethanolamine, phosphatidylinositol, phosphatidylserine, phosphatidylglycerol, phosphatidic acid, lysophosphatidylcholine, sphingomyelin, egg yolk lecithin, ^ a lecithin Phospholipids or silicon-added phospholipids, cholesterols such as cholesterol, cholesterol alkyl esters, phytosterols, phytosterol alkyl esters, glyceglycoglycolipids, asildarcosides such as cetylgalactoside, dialkyl-type synthetic surfaces Active I4, N-acylsphingosine or its sulfate ester, N-acylsphingoglycolipid, N-higher acyl dirtathion or a mixture of tt ^ S or more It is below. In addition, decorative alcohols, higher alcohols, high and full fatty acids, and the like can be added as necessary to stabilize ribosomes or improve phase transition.
海消罙層水は、 表面海水が沈降していて層を形成しているもので低温、清浄で栄養塩に富 む固有水であり、 その ¾τΚ海域は 1 0 0 0〜4 0 0 0 m、好ましくは 2 0 0 0〜3 0 0 0 m であり、 取水深度は 2 5 0〜5 0 0m、好ましくは 3 0 0〜4 0 0 mである。海洋深層水は、 数知れない多くのミネラルを含有していることから、 保湿性に優れ、 また、 ?¾Sf生に優れて いることから、化粧料に配合させている 成分の皮膚内への?通を促すと考えられる。海 觸層水の配^ *は通常 4 0 - 9 9 %であり、 好ましくは 5 0〜 6 0 %である。  Sea extinguisher water is a natural water rich in nutrients that is low in temperature, clean, and rich in nutrients. The water intake depth is 2500-0500m, preferably 3200-0400m. Since deep ocean water contains numerous minerals, it has excellent moisture retention. ¾Sf is excellent in raw life, which is thought to promote penetration of ingredients contained in cosmetics into the skin. The distribution of the seabed water is usually 40 to 99%, preferably 50 to 60%.
好ましい任意の酉己合成分をさらに具体的に説明する。 油脂類としては、 ホホパ、油、 ヒマシ油、 ォリーブ油、 油、 ヤシ油、 パーム油、 カカオ 油、 ミンク油、 タートル油等が挙げられる。 The preferred optional self-synthesized component will be described more specifically. Examples of the fats and oils include jojoba, oil, castor oil, olive oil, oil, coconut oil, palm oil, cacao oil, mink oil, turtle oil and the like.
炭化水素類としては、 «Iパラフィン、 ワセリン、 マイクロクリスタリンワックス、 スク ヮラン等が挙げられる。  Examples of hydrocarbons include I paraffin, petrolatum, microcrystalline wax, and squalene.
ロウ類としては、 ミツロウ、 ラノリン、 カルナバロウ、 キャンデリラロゥ等が挙げられる。 月旨肪酸としては、 ミリスチン酸、 パルミチン酸、 ステアリン酸、 ォレイン酸、 イソステア リン酸、 ラウリン酸等が、挙げられる。  Examples of waxes include beeswax, lanolin, carnauba wax, and candelillaro. Examples of lunar fatty acids include myristic acid, palmitic acid, stearic acid, oleic acid, isostearic acid, lauric acid and the like.
合成エステル類としては、 ミリスチン酸イソプロピル、 パルミチン酸イソプロピル、 ォレ イン酸プチル、 ミリスチン酸ミリスチル、 ミリスチン酸ォクチルドデシル、 モノステアリン 酸プロピレングリコール、 ? L酸ミリスチル、 リンゴ酸イソステアリル、 モノステアリン酸グ リセリン、 塩化ジステアリルジメチルァンモニゥム等が挙げられる。  Synthetic esters include isopropyl myristate, isopropyl palmitate, butyl oleate, myristyl myristate, octyldodecyl myristate, propylene glycol monostearate,? Examples include L myristyl L, isostearyl malate, glyceryl monostearate, and distearyl dimethyl ammonium chloride.
油脂類、 炭化水素、 ロウ類、 月旨肪酸、 合成エステ は、 通常あわせて。〜 5 Ow/w% の割合で配合される。  Oils, hydrocarbons, waxes, lunar fatty acids, synthetic esthetics are usually combined. It is blended at a ratio of ~ 5 Ow / w%.
アルコール類としては、 エタノール、 1, 3—ブチレングリコール、 プロピレングリコー ル、 ラウリルアルコール、 セタノール、 ステアリルアルコール、 ォレイルアルコール等が挙 げられる。  Examples of alcohols include ethanol, 1,3-butylene glycol, propylene glycol, lauryl alcohol, cetanol, stearyl alcohol, and oleyl alcohol.
アルコール類は、 通常 0〜1 OwZw%の割合で配合される。  Alcohols are usually blended at a ratio of 0 to 1 OwZw%.
界面活' I4^|Jとしては、 グリセリン脂肪酸エステル類、 ソルビタン脂肪酸エステル類、 ポリ ォキシエチレン脂肪酸エステル類、 ポリオキシエチレンソルビタン脂肪酸エステル類、 ポリ ォキシエチレンアルキルェ一テル類、 ヤシ油脂肪酸モノエタノールアミド、 ポリオキシェチ レン硬化ヒマシ油、 ラウリル硫酸ナトリウム、 ピログルタミン酸イソステアリン酸ポリオキ シエチレンダリセリル、 アルキルベンゼンスルホン酸ナトリゥム、 ポリォキシエチレンステ ァリルエーテル、 ジアルキルスルホコハク酸、 臭化セチルピリジニゥム、 塩化— n—ォク夕 デシルトリメチルアンモニゥム、 モノアルキルリン酸、 N—ァシルスル夕ミン酸、 N—ァシ ルグルタミン、 ショ糖脂肪酸エステル、 ポリオキシエチレンソルビタンモノステアレ一ト、 ポリォキシエチレンラウリルエーテル硫酸ナトリゥム、 ポリォキシエチレン ¾ラノリン等 が挙げられる。 界面活' 14^1は、 通常 0〜2w/w%の割合で配合させる。 Surfactant 'I4 ^ | J includes glycerin fatty acid esters, sorbitan fatty acid esters, polyoxyethylene fatty acid esters, polyoxyethylene sorbitan fatty acid esters, polyoxyethylene alkyl ethers, coconut oil fatty acid monoethanolamide , Polyoxyethylene hydrogenated castor oil, sodium lauryl sulfate, polyoxyethylene darericyl pyrostearate, sodium alkylbenzene sulfonate, polyoxyethylene stearyl ether, dialkylsulfosuccinic acid, cetylpyridinium bromide, n-o chloride Decyltrimethylammonium, monoalkyl phosphate, N-acylsulfuric acid, N-acylglutamine, sucrose fatty acid ester, polyoxyethylene sorbitan monostearate And polyoxyethylene lauryl ether sodium sulfate, polyoxyethylene and lanolin. The surface activity '14 ^ 1 is usually added at a rate of 0 to 2 w / w%.
増粘剤としては、 力ルポキシビ二ルポリマー、 メチルポリシロキサン、 デキストラン、 力 ルポキシメチルセルロース、 カラギーンナン、 ヒドロキシプロピルメチルセルロース等が挙 げられる。  Examples of the thickener include strong lpoxyvinyl polymer, methylpolysiloxane, dextran, strong lpoxymethylcellulose, carrageenan, and hydroxypropylmethylcellulose.
増粘剤は、 通常 0〜 1 wZw%の割合で配合される。  The thickener is usually blended at a ratio of 0 to 1 wZw%.
保湿剤としては、 グリセリン、 プロピレングリコール、 1 , 3—ブチレングリコ一ル、 プ 口グルタミン酸、 ァセチルダルタミン酸、 ヒアルロン酸、 プロシァニジン等が挙げられる。 保湿剤は、 通常。〜 5 w/w%の割合で配合される。  Examples of the humectant include glycerin, propylene glycol, 1,3-butylene glycol, puffer glutamic acid, acetyl tiltamic acid, hyaluronic acid, procyanidine and the like. Moisturizer is usually. It is blended at a rate of ~ 5 w / w%.
防腐剤としては、 安息香酸、 サリチル酸、 デヒドロ酢酸あるいはそれらの塩類、 パラォキ シ安息香酸エステル類のフエノール類、 トリク口サンハロカルバン等カ攀げられる。  Examples of preservatives include benzoic acid, salicylic acid, dehydroacetic acid or salts thereof, phenols of parabenzoic acid esters, and tricky sanhalocarban.
防腐剤は、 通常 0〜0 · 3wZw%の割合で配合される。  The preservative is usually blended at a ratio of 0 to 0 · 3wZw%.
香料は、 通常化粧料にィ魏するものであればどのような香料を用いてもよい。  Any fragrance may be used as long as it is generally used for cosmetics.
顔料としては、 酸化鉄、 二酸化チタン、 酸ィ bffi鉛、 カオリン、 タルク等が挙げられる。 鎮料は、 通常 0〜 1 wZw%の割合で配合される。  Examples of pigments include iron oxide, titanium dioxide, acid bffi-lead, kaolin, and talc. The prescription is usually blended at a rate of 0 to 1 wZw%.
觀 IJとしては、 小麦 油、 ビタミン A、 ビタミン B 2、 ビタミン E、 アスコリレビン酸一 2—リン酸マグネシウムあるいはナトリウム、 D—パントテールアルコール、 グリチルリチ ン酸ジカリウム、 ダルタチオン、 UV吸収剤、 キレート剤、 植物抽出物、 微生物代謝物 Z抽 出物等が挙げられる。 觀 IJ includes: Wheat oil, Vitamin A, Vitamin B 2, Vitamin E, Ascorbile acid mono-2-magnesium or sodium phosphate, D-Pantole alcohol, Dipotassium glycyrrhizinate, Dartathione, UV absorber, Chelating agent, Examples include plant extracts and microbial metabolite Z extracts.
W , 通常 0〜 3 w/w%の割合で配合される。  W, usually 0 to 3 w / w%.
水性謝の水としては、 水道水、 ミネラルウォーター、 かん水、 海水、 超純水、 極¾¾<由 As water for water, tap water, mineral water, brine, seawater, ultrapure water,
¾ - ^ 精製水等が挙げられる。 水は任意の割合で配合される。 ¾- ^ purified water and the like. Water is blended in an arbitrary ratio.
酵母、 酵母抽出液、 なかでも酵母細胞壁である —ダルカンは、 ^mi動 I'生の高い高織 造を有しているため、 T細胞、補体系などの免疫増強に関わる種々の細胞や活性化や増量が 報告されており、 錦な生物活性を持っているが、 その一方で、 物質、 肝レベルでの作用 ¾|冓の角科斤は、 ほとんどなされていない。 しかし、 皮膚免疫で主要な働きをするのは表皮ラ ンゲル八ンス細胞であり、 これは、外部からの 等があると、 その情報を Τ細胞に伝える という 提示機能を持つ。 したがって、 この Τ細胞を るものを化粧料に配合すること は、 »の敲を中心としたケアによる老化防止とは異なり、 生体系そのものの免疫機能の 向上を示すものである。 また、 これらに皮膚への? ¾t性の高い海 ^層水、 さらには保湿、 柔 果を有する成分ゃ抗酸化力を有する成分を配合することで皮膚免疫機能の一度の向 上を図ることが^ =きる。 Yeast, yeast extract, especially yeast cell wall —Dalcan has a high texture of ^ mi kinetic I ', so various cells and activities related to immune enhancement such as T cells and complement system It has been reported that it has a slight biological activity, while it has a brilliant biological activity, but on the other hand, there is almost no horn | However, epidermal Langer-octance cells play a major role in skin immunity, and have the presentation function of transmitting information to sputum cells when there is an external source. Therefore, it is necessary to mix these cells with cosmetics. Unlike the prevention of aging through care centering on »», it shows an improvement in the immune function of the biological system itself. In addition, it is possible to improve the skin immunity function once by blending these with sea layer water that has a high degree of skin property, as well as ingredients that have anti-oxidant power and moisturizing and soft ingredients. ^ = Kiru.
«の皮膚老化防止化粧料は、 (季節的変化による) 肌荒れや、 皮膚機能の一時的な低下 により生じる皮膚トラカレ等を中心に作用するものであつたが、近年増加する義肌人間等 の生体系全体の失調に起因する腦れには、その人の生体系全体のバランスを改善する必要 がある。本発明の P跪された) S—ダルカンを配合した皮膚化粧料は、 艘系に作用し、 生体 系のバランスを肌機能内部より改善するものである。勿論その人体への影響は非常に線口な ものである。  «Skin aging prevention cosmetics act mainly on rough skin (due to seasonal changes) and skin trauma caused by temporary deterioration of skin function. Drowning due to systemic malfunction requires an improvement in the balance of the person's entire biological system. The skin cosmetics containing S-Dalcan (P-P) of the present invention acts on the wrinkle system and improves the balance of the biological system from the inside of the skin function. Of course, the effect on the human body is very sensible.
本発明の皮膚化粧料は徹用いられていた難溶性 一グルカンでは配合不可能であった 水溶性および透明な剤形の水性化粧料(たとえば化 に関しても、 配合可能となり、 化 粧料剤形を選ばずに用いることがij能である。 また皮膚への霞に優れており、 藤に優れ た皮膚老化防 果を示す。  The skin cosmetics of the present invention have been used poorly solubilizing monoglucans that could not be formulated with water-soluble and transparent dosage forms of aqueous cosmetics (for example, chemicals can be formulated, and cosmetic cosmetic dosage forms The ij ability is used regardless of the choice, and is excellent in wrinkling on the skin, and exhibits excellent skin aging prevention effects on wisteria.
さらに、低 の β―グルカンを用いることにより、そのリポソームへの 率が飛 躍的に向上し、 β—ダルカンをより多く搬したリボソーム «の調製が初めて可能となる。 これにより、 iS—ダルカンの皮膚への? 1¾量ならびに?! MSヵ梗に向上し、 より高いスキ ンケア効果 (保湿、 はり、 しわ、 皮膚のターンオーバー等) を得ること力河能となる。  Furthermore, by using a low β-glucan, the rate of liposomes is dramatically improved, and it becomes possible for the first time to prepare a ribosome carrying more β-dulcan. As a result, the amount of iS-Dalcan on the skin? ! Improves MS MS and gains higher skin care effects (moisturizing, acupuncture, wrinkles, skin turnover, etc.).
実施例 Example
次に本発明を実施例によって例証するが、 本発明はこれらに限られるものではない。  EXAMPLES Next, the present invention will be illustrated by examples, but the present invention is not limited to these examples.
実施例 1 : Example 1:
酵 胞からの可溶性 iS— 1 , 3/ 1 , 6— D—グレカンの調製 Preparation of soluble iS-1, 3/1, 6- D-Grecan from the fermentation
酵働睏 に 1 0倍量の 1. 5 Nの水酸化ナトリゥムを攪拌下で添加し、 次いで混合物を 6 0°Cで 3 0分間加熱を行った。 この加熱混合物を、 1 5分間 1 5 p s iで 1 2 Cの条件の 下、 オートクレープで処理を行った。その後、 加熱混合物を冷却し、 遠心分離を行い、 上澄 みを歹紛から分離した。残分を、 1 0倍量の水で 1 5分間攪拌しながら、 zK洗した。遠心分 離によって上澄み液を分離した後、 3 7°Cで 1 0倍量の 3 %酢 ¾ _Κ謹を加え、 8 5°Cで 4 5分間纖拌を行った。その後、 混合物を し、 遠心分離にて上澄みを歹紛から分離した。 この譲の /3— 1, 3/1, 6— D—グルカン歹紛を、 15分間攪拌しながら水洗した。 酵鶴細纏を 37°Cで 10倍量の 3%のアセトン水溶 処理し、歹纷を添加し 85°Cに 加温し 45分間攪拌した。水で残分を洗浄した後、 15-75 %の次亜: *酸ナトリゥムで 処理した。 (好ましい条件は 20%の濃度で、 温度が 4〜150°C、 更に好ましくは 50°C で 15分から 48時間の処理である) 歹纷を数回水洗した。 To the fermenter, 10 times the amount of 1.5 N sodium hydroxide was added with stirring, and the mixture was then heated at 60 ° C. for 30 minutes. The heated mixture was autoclaved for 15 minutes at 15 psi and 12 C conditions. Thereafter, the heated mixture was cooled and centrifuged to separate the supernatant from the powder. The residue was washed with zK while stirring with 10 times the amount of water for 15 minutes. After separating the supernatant by centrifugation, add 10 times the amount of 3% vinegar ¾_Κ 謹 at 37 ° C, and add 4% at 85 ° C. Stir for 5 minutes. Thereafter, the mixture was separated, and the supernatant was separated from the powder by centrifugation. The / 3-1, 1, 3/1, 6-D-glucan powder from this concession was washed with water with stirring for 15 minutes. The fermented crane was treated with 10% 3% acetone in water at 37 ° C, koji was added, heated to 85 ° C, and stirred for 45 minutes. After washing the residue with water, it was treated with 15-75% of hypochlorous acid: * sodium acid. (Preferable conditions are a 20% concentration, a temperature of 4 to 150 ° C., more preferably 50 ° C. for 15 minutes to 48 hours.) The straw was washed several times.
粗製 (不溶'附 の /3— 1, 3/1, 6— D—グルカンを、 3倍量の水に分散し、 40 で さらに 20〜25倍量の水に满口した。 この混合' 夜に、 NovoNard i sk, Far nk 1 i t on, N. C. より '購入した V i s c o zyme L-β-Ι, 3/1, 6— D —ダルカナ一ゼ (B i oc a t a lys t s Ltd. Pon ty r i dd, UK製の T P654/2 Pその他の /3—ダルカナーゼでもよい) を 100m 1加え、 80 で加赛機拌 した。次いでこの 蜀液を 100000ダルトンの ίΗ¾をカツトするフィルターを備えた 糸纖隹状フィルターを通して分離した。 これを 10時間繰り返し行い、 常に 80°Cの水を通す Crude (insoluble / 3-1, 1, 3/1, 6- D-glucan was dispersed in 3 times the amount of water and sprinkled into 40 to 20 to 25 times the amount of water. From NovoNard i sk, Far nk 1 it on, NC 'Purchased V isco zyme L-β-Ι, 3/1, 6— D —Darkanaize (B i oc ata lys ts Ltd. Pon ty ri dd, 100 ml of TP654 / 2 P or other 3 / 3-dalcanase from UK) was added and stirred at 80. The suspension was then threaded with a filter to cut 100000 daltons Separated through a filter, repeated for 10 hours, always passing water at 80 ° C
(加える) ことで、 反応管内を一定舗に保った。 濾過物を 10時間以 ¾镜的に集め た。ィ翻をコロイド状の 0— 1, 3/1, 6— D—グルカンを調製するために用いた。 減 つていく糖の量は、 1リットルごとに採取した ½¾i物内で確認した。 濾過物を、 1 500の ^Τ*をカットする中空の繊佳内を通して分画し、 塩や低^ «の色素、糖を透析 した。透析は、外側の中空繊隹を水速 800ml /m i ηの速さで通して水を汲み上げるこ とで行った。 そして 10Β寺間後、 14. 5リットルの險 物を採取した。 Ρ跳濾過物を 逆浸透膜で濃縮し、 次いでロータリ一エバポレイターによって?謹した。 10倍量の 95% エタノールで 键過物を一日免御することで、 β-1, 3/1, 6— D_ダルカンを?顱宿 品から 物として得た。 (Adding) By keeping the inside of the reaction tube constant. The filtrate was collected over 10 hours. This was used to prepare colloidal 0-1, 1, 3/1, 6-D-glucan. The amount of sugar to be reduced was confirmed in the sample collected every liter. The filtrate was fractionated through a hollow fiber that cuts 1,500 ^ Τ * and dialyzed against salt, low-color pigment, and sugar. Dialysis was performed by pumping water through the outer hollow fiber at a water speed of 800 ml / m i η. And after 10 temples, 14.5 liters of food were collected. The hopping filtrate was concentrated with a reverse osmosis membrane and then filtered with a rotary evaporator. Β-1, 3/1, 6-D_Dalcan was obtained as a product from a food product by exempting the filter material with 10 times the amount of 95% ethanol for one day.
物を集め、 95%エタノールで洗诤し、 乾燥した。 (髓機能を有する完全可溶性 jS — 1, 3/1, 6 - D—グルカン:^? ¾3、布 4141〜250208、 平均籽量 =47 457ダルトン、 分散率 =1. 43。 このうち 75%は 37121〜83902ダリレトンの 範囲の^ ¾であった) ' ΛΙ 00000のカツト能を持つ膜の保論からの3— 1, 3 /1, 6—D—グルカンを 10倍量の 95%エタノールを用いて、 一晩中低温下で灕宿し限 外濾過物から沈降させた。 耀物を集め 95%エタノールで洗浄し、 乾燥した (コロイド状 の β -グルカン;: ^布 13148〜473616タレトン、平均: 1474 20ダルトン、 、散率 =1. 90。 このうち 75%は 91510〜256863タレトンの 範囲の: であった)。 The material was collected, washed with 95% ethanol and dried. (Completely soluble jS with cocoon function — 1, 3/1, 6-D—glucan: ^? ¾3, cloth 4141 to 250208, average cocoon weight = 47 457 daltons, dispersion rate = 1.43. Of these, 75% It was ^ ¾ in the range of 37121 to 83902 Dali Reton) 'Using 3: 1, 3/1, 6-D-glucan 10 times the amount of 95% ethanol from the theory of membranes with cutting ability of ΛΙ00000 And stay at low temperature all night long It was allowed to settle from the outer filtrate. Collected porridge, washed with 95% ethanol, dried (colloidal β-glucan ;: ^ cloth 13148-473616 Taleton, average: 1474 20 Dalton, scatter rate = 1.90. Of which 75% is 91510- 256863 of Taleton range :).
乾燥した沈殿物は、 さらにクロマトグラフィー (親和力、 透析、 クロマトなど)、 または 様々な^ ¾を選択! ^できるフィル夕一を用いた透析などによって精製される。  The dried precipitate is further purified by chromatography (affinity, dialysis, chromatography, etc.) or by dialysis using a filter that can select various ¾.
完全可溶性 /3— 1, 3/1, 6— D—ダルカンの物性値を示す。  Completely soluble / 3— 1, 3/1, 6— D—Shows the physical properties of Dalkan.
免疫機能を る可溶性 /3—1, 3/1, 6—D—グルカンの物性値 Soluble / 3-1-1, 3/1, 6-D-glucan properties with immune function
^ Μ: 12000— 60000タリレトン  ^ Μ: 12000—60,000 talileton
可溶性; 2. 5 gm/ml  Soluble; 2.5 gm / ml
水中での色;明るいベージュ  Underwater color; light beige
280 nmでの ¾¾¾ ; 2632  ¾¾¾ at 280 nm; 2632
1%水溶液の pH 7. 0  PH 7.0 of 1% aqueous solution
β— 1, 3結合% 83  β-1,3 bond% 83
β - 1, 6結合% 17  β-1, 6% bond 17
β-l, 4 % 無し (測定不能)  β-l, 4% None (not measurable)
実施例 2: Example 2:
雄例 1の方法に従つた方法で調製した繊機能を^ る可溶性 β―ダル力ン 約 The soluble β-Dal force that has a fine function prepared by the method of Male Example 1.
50000タレトン) を 0. 05 %配合した化 ¾τΚを作成し、 女性 100人の顔に朝晚、 8 週間^した結果を示す。 なお、 本試験は被^1としてスペシャリストを起用し、 細人が 棚後どのように感じたカゝをモニタ一した結果である The result of making ¾τΚ containing 0.05% Taleton) in the morning is 8 weeks on the face of 100 women. The present test was hired specialists as the ^ 1 is the result of Hosohito was monitored scratch mosquitoゝfelt how after shelf
(処方例. 1) 酵母抽出物 (可溶性 —ダルカン;  (Formulation example. 1) Yeast extract (soluble—Dalcan;
肝量約 50000タレトン) 0. 05  Liver volume approx. 50,000 Tareton) 0. 05
赤ワイン酵母抽出液 0. 1  Red wine yeast extract 0.1
海觀層水 (逆浸透膜麵済み) 50. 0 レシチン 1. 0 Ridge water (reverse osmosis membrane) 50. 0 Lecithin 1.0
コレステロール 0. 5  Cholesterol 0.5
才レイン酸 0. 5  Age Rain Acid 0.5
グリセリン 3. 0  Glycerin 3.0
1, 3—ブチレングリコール 7. 0  1, 3-butylene glycol 7.0
L—アルギニン 0. 25  L—Arginine 0.25
飽和脂肪酸グリセリル 1. 0  Saturated fatty acid glyceryl 1.0
グリセリン脂肪酸エステル 1. 5  Glycerin fatty acid ester 1.5
高級アルコール 0. 5  Higher alcohol 0.5
雜アルコール脂肪酸エステル 0. 5  雜 Alcohol fatty acid ester 0.5
保湿剤 0. 5  Moisturizer 0.5
防腐剤 0. 5  Preservative 0.5
を 100に調整  Adjust to 100
® 方法は、 定法に従い調製し、 乳液とした。  ® The method was prepared according to a conventional method and used as an emulsion.
なお、 ここで用いた海消荣層水 (逆疆縢慮過済み) とは、 海 荣層水原水を逆羅 膨慮過によって処理された水である。  The seawater layer water used here (reverse consideration) is the water that has been treated by retreating the ocean.
功果 改善率 (%)  Achievement improvement rate (%)
28日後(4週間衝 56日後(8週間^)  28 days later (4 weeks after 56 days (8 weeks ^)
64% 80%  64% 80%
肌のはり 45% 68%  Skin tension 45% 68%
肌のこじわ 22% 66%  Skin wrinkles 22% 66%
以上の結果から明らかなように、 約 4週間の使用で半分以上の人が肌の保湿感の改善 効果があると ¾ し、 さらに 8週間 ί®1することで 80%の人が保湿感の改奢効果が見 られることがわかった。  As can be seen from the above results, more than half of the people after about 4 weeks of use have an effect of improving the moisturizing feeling of the skin. It was found that tampering effects were observed.
また、肌のはりに関しても 8週間翻することによって半分以上の人に改善が見られ 肌の小皺においてはかなりの改善が認められた。  In addition, more than half of the skin was improved by turning over the skin for 8 weeks, and a considerable improvement was observed in the skin wrinkles.
実施例 3: 実施例 1の方法に従った方法で調製した可溶性グルカン 約 8 0 0 0〜1 0 0Example 3: Soluble glucan prepared by a method according to the method of Example 1 from about 800 to 100
0 0ダルトン) を0. 0 5 %配合した乳液を作成し、 女性 1 0 0人の顔に朝晩、 8週間 使用したのち、 その肌のしわ状態を目視により を行い、 改善度合いをグラフにした 結果を図 1に示す。 (なお、 は雄例 2に示したとおりである。) 0% Dalton) was prepared, and it was used on women's faces in the morning and evening for 8 weeks. The skin wrinkled condition was visually observed and the degree of improvement was graphed. The results are shown in Figure 1. (In addition, is as shown in male example 2.)
グラフからも明らカ よように、 8週間の細によって、 肌におけるしわ力溝くなり改 善されたことがわかった。  As can be seen from the graph, it was found that the wrinkles in the skin were improved by the fineness of 8 weeks.
実施例 4: Example 4:
実施例 1の方法に従つた方法で調製した可溶性ダル力ン 钓 1 0 0 0 0ダルト ン) を 0. 0 5 %配合した乳液を作成し、 女 I生 1 0 0人の顔に朝晩、 8週間使用したの ち、その肌表面の怃態をレプリカに取り、改善率を検討した結果を図2に示す。 (なお、 は実施例 2に示したとおりである。) A milk containing 0.1% 5% soluble dull force prepared by the method according to the method of Example 1 was prepared. Fig. 2 shows the results of examining the skin surface condition in a replica after 8 weeks of use and examining the improvement rate. (In addition, is as shown in Example 2.)
いずれの場合においても、 使用前には確認された斜めに存在している f i n e w r In any case, it exists diagonally confirmed before use f i n e w r
1 n k 1 eの線が、 翻後 8週間後には殆ど目立たなくなつていることがわかり、 肌の 保麵果が 善され、 f i n e w r i n k 1 eが目立たなくなつていることがわかつ た。 It was found that the line of 1 n k 1 e became almost inconspicuous after 8 weeks, and that the skin's protective effect was improved and that f i n w r i n k 1 e became inconspicuous.
難例 5: Case 5:
実施例 1の方法に従つた方法で調製した可溶' I生クレカン ½H¾約 5 0 0 0 0夕レ卜 ン) を 0. 0 5 %配合した乳液を作成し、 女性 1 0 0人の顔に朝晩、 8週間使用したの ち、 その肌の角質層の状態に関して、 テープストリッピング試験を行い、 その改善率に つき検討を行った結果を図 3に示す。 (なお、 処方は実施例 2に示したとおりである。) このテープストリツビングの結果から、 いずれの においても、 翻前にはケラチ ノサイトの被が 認されたが、 使用後 8週間後には殆ど目立たなくなつていることが わかり、 角質層が健常な状態に改善されていることがわかった。  An emulsion containing 0.05% of soluble 'I raw klecan ½H¾ approximately 5 0 0 0 0 evening lens) prepared by the method of Example 1 was prepared. Fig. 3 shows the results of a tape stripping test on the condition of the stratum corneum of the skin after using it for 8 weeks in the morning and evening, and examining the improvement rate. (The prescription is as shown in Example 2.) From the results of tape stripping, keratinocyte coverage was recognized before conversion in any of the cases, but 8 weeks after use. It turned out to be almost inconspicuous, and the stratum corneum was improved to a healthy state.
なお、 ケラチノサイトの部分が多く; i¾Tるほど角質層の重層剥離を示しており、 肌 状態は健常でないことを示す。  It should be noted that the more keratinocytes are present; i¾T indicates delamination of the stratum corneum, indicating that the skin condition is not healthy.
実施例 6: Example 6:
実施例 1の方法に従った方法で調製した可溶性ダルカン 約 5 0 0 0 0ダルト ン) を 0. 0 5 %配合した乳液を作成し、 女性 1 0人の上腕に朝晩、 4週間翻したの ち、 その肌のターンオーバーの状態について、 テープストリッピング法により試験を行 つた。その改善率の結果を図 4に示す。 (なお、処方は実施例 2に示したとおりである。) テープストリッビングによって採取した角質層を顕微鏡で した結果にも示される ように、 予め肌を荒らした 態では角質層の重層剥離 (色が濃くなつている部分) が見 られ その後何も塗布しなぃ 態では肌細胞の 態は更に 匕し、 細胞の核までが黒点 状になってみられたが、 可溶性 )3—グルカンを配合した乳液を塗; flfTることにより、 そ の角質層の犹態は改善され健常な肌 態に近づき、 角質層のターン才ーパ、一が、 «され ていることがわかった。 Soluble dulcan prepared by a method according to the method of Example 1 about 5 0 0 0 0 dart Was prepared on the upper arm of 10 females for 4 weeks, and the skin turnover state was tested by the tape stripping method. Figure 4 shows the results of the improvement rate. (The prescription is as shown in Example 2.) As shown in the result of microscopic examination of the stratum corneum collected by tape stripping, the stratum corneum was peeled off in the state where the skin was previously roughened (color). In the case where nothing is applied after that, the skin cell state further deteriorated, and even the cell nucleus was seen as black spots, but it was soluble) 3) Glucan included It was found that by applying the latex, flfT improved the skin condition of the stratum corneum and brought it closer to a healthy skin condition.
図面の簡単な説明 Brief Description of Drawings
図 1は実施例 3のしわの改善結果 (目視による) を示すグラフ。  Fig. 1 is a graph showing the wrinkle improvement results (visually) of Example 3.
図 2は実施例 4のしわの改善結果 (レプリカによる鶴) を示すグラフ。  Fig. 2 is a graph showing the wrinkle improvement results (crane by replica) of Example 4.
図 3は実施例 5の角質層の改善結果を示すグラフ。  FIG. 3 is a graph showing the improvement results of the stratum corneum in Example 5.
図 4は実施例 6の角歸田胞の改善結果を示すダラフ。  FIG. 4 is a draaf showing the improvement result of Kakuda rice cyst of Example 6.

Claims

請求の範囲 The scope of the claims
1. 酵母由来の β—ダル力ンの精 M程で /3—ダルカナーゼを用いることを樹敫とす る免疫機能を る可溶性 jS—グルカン (可溶性酵母べ一夕 1, 3Z 1 , 6—D—ダル カン.酵母及び/又は酵母抽出物) の 法。 1. Soluble jS-glucan with an immune function based on the use of / 3-Dalcanase at the level of ß-Dal force of yeast-derived (soluble yeast, 1, 3Z 1, 6-D —Dalkan. Yeast and / or yeast extract) method.
2. 免疫機能を ¾Tる可溶性 /3—グルカン (可溶性酵母ベータ 1 , 3/ 1 , 6— D— グルカン .酵母及び ζ又は酵母抽出物) を含^ ることを精敷とする皮膚化粧料。 2. A skin cosmetic composition that contains a soluble / 3-glucan (soluble yeast beta 1, 3/1, 6-D-glucan. Yeast and ζ or yeast extract) having an immune function.
3. 水敝膚化粧料である請求項 2記載の皮膚化粧料。 3. The skin cosmetic according to claim 2, which is a water skin cosmetic.
4. リポソーム分散液の状態にある請求項 2又は 3記載の皮膚化粧料。  4. The skin cosmetic according to claim 2 or 3, which is in the form of a liposome dispersion.
5. さらに海洋深層水を含有する請求項 2〜 4のレ ^ずれか 1項記載の皮膚化粧料。  5. The skin cosmetic according to claim 2, further comprising deep ocean water.
PCT/JP2003/016979 2002-12-27 2003-12-26 PROCESS FOR PRODUCING SOLUBLE β-GLUCAN HAVING IMMUNOLOGICAL FUNCTION AND USE THEREOF WO2004061115A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002-380285 2002-12-27
JP2002380285A JP2004210895A (en) 2002-12-27 2002-12-27 METHOD FOR MANUFACTURING SOLUBLE beta-GLUCAN HAVING IMMUNE FUNCTION, AND ITS USE

Publications (1)

Publication Number Publication Date
WO2004061115A1 true WO2004061115A1 (en) 2004-07-22

Family

ID=32708430

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2003/016979 WO2004061115A1 (en) 2002-12-27 2003-12-26 PROCESS FOR PRODUCING SOLUBLE β-GLUCAN HAVING IMMUNOLOGICAL FUNCTION AND USE THEREOF

Country Status (2)

Country Link
JP (1) JP2004210895A (en)
WO (1) WO2004061115A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105310078A (en) * 2007-05-08 2016-02-10 生物高聚物工程公司Dba生物治疗公司 Particulate-soluble glucan preparation

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4979924B2 (en) * 2004-11-16 2012-07-18 アサヒグループホールディングス株式会社 Method for producing yeast water-soluble polysaccharide
JP4545063B2 (en) * 2005-08-05 2010-09-15 キリンホールディングス株式会社 Skin condition improving composition
JP5153188B2 (en) * 2007-03-30 2013-02-27 小林製薬株式会社 Th1 / Th2 balance improver
KR100812129B1 (en) 2007-09-07 2008-03-11 신석봉 Cosmetic compositions comprising vitamin c and soluble beta glucan for preventing skin aging
JP5172930B2 (en) * 2009-10-20 2013-03-27 国立大学法人佐賀大学 Method for reducing the viscosity of highly viscous cultures
GB201501799D0 (en) * 2015-02-03 2015-03-18 Tate & Lyle Sweden Ab Methods of producing liquid compositions
JP6666084B2 (en) * 2015-07-03 2020-03-13 フィンガルリンク株式会社 Natural immunity level evaluation method and product containing baker's yeast beta-glucan for improving natural immunity level
JP7181715B2 (en) * 2018-07-13 2022-12-01 学校法人君が淵学園 β-glucan derived from torula yeast
CN112076209A (en) * 2019-06-14 2020-12-15 青岛海洋生物医药研究院股份有限公司 Beta-glucan composition and application thereof
JPWO2022244580A1 (en) * 2021-05-21 2022-11-24
WO2023074808A1 (en) * 2021-10-28 2023-05-04 三菱商事ライフサイエンス株式会社 Yeast extract with excellent texture

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0466037A2 (en) * 1990-07-06 1992-01-15 As Biotec-Mackzymal Process for enhancing the resistance of aquatic animals to disease
JPH06340701A (en) * 1993-06-01 1994-12-13 Nippon Oil Co Ltd Highly branched beta-glucan, its production and use
WO1995030022A1 (en) * 1994-04-29 1995-11-09 A/S Biotec-Mackzymal Enzyme treatment of glucans
EP0875244A2 (en) * 1997-05-02 1998-11-04 Ciba SC Holding AG Cosmetically accceptable microstructured compositions
WO2002051361A1 (en) * 2000-12-22 2002-07-04 Shu Uemura Cosmetics Inc. Skin cosmetics

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0466037A2 (en) * 1990-07-06 1992-01-15 As Biotec-Mackzymal Process for enhancing the resistance of aquatic animals to disease
JPH06340701A (en) * 1993-06-01 1994-12-13 Nippon Oil Co Ltd Highly branched beta-glucan, its production and use
WO1995030022A1 (en) * 1994-04-29 1995-11-09 A/S Biotec-Mackzymal Enzyme treatment of glucans
EP0875244A2 (en) * 1997-05-02 1998-11-04 Ciba SC Holding AG Cosmetically accceptable microstructured compositions
WO2002051361A1 (en) * 2000-12-22 2002-07-04 Shu Uemura Cosmetics Inc. Skin cosmetics

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105310078A (en) * 2007-05-08 2016-02-10 生物高聚物工程公司Dba生物治疗公司 Particulate-soluble glucan preparation
CN105310078B (en) * 2007-05-08 2018-03-30 生物高聚物工程公司Dba生物治疗公司 It is prepared by particulate-soluble glucan

Also Published As

Publication number Publication date
JP2004210895A (en) 2004-07-29

Similar Documents

Publication Publication Date Title
KR102156898B1 (en) Ingestible cosmetic composition for skin whitening, skin moisturizing, antioxidant, anti-inflammatory, skin barrier strengthening and skin absorption containing the lactic acid fermentation mixture
JP5108025B2 (en) Extract obtained from orchidaceae plant, method for producing the same, and skin external preparation containing extract obtained from orchidaceae plant
WO2009084200A1 (en) External skin preparation for pimpled skin
EP2694030A2 (en) Cosmetic formulations
KR20110108686A (en) Antioxidant containing extracts of natural materials and composition of feed, food or cosmetic
EP0818200B1 (en) Use of polysaccharide to stimulate desquamation of the skin and compositions containing it
WO2004061115A1 (en) PROCESS FOR PRODUCING SOLUBLE β-GLUCAN HAVING IMMUNOLOGICAL FUNCTION AND USE THEREOF
JP5383963B2 (en) Humus, humus extract and moisturizing liquid, and their production and use
WO2014170595A1 (en) Cosmetic and pharmaceutical applications of lactobacillus pentosus
WO2008032134A1 (en) Method for obtaining yeast glucan by autolysis of saccharomyces cerevisiae baker&#39;s yeast cells
CN107648087B (en) Whitening antioxidant skin cream and preparation method thereof
CN113384513A (en) Preparation method of yeast fermentation product filtrate and application of yeast fermentation product filtrate in cosmetics
KR101662272B1 (en) Natural cosmetic composition for skin moisturizing comprising Mixed extract of barley and germ and rice bran of black rice and preparation method thereof
JP3184114B2 (en) Moisturizer
KR20210093662A (en) Cosmetic composition comprising seaweed extracts
WO2015012198A1 (en) Moisturizing agent
KR20180082058A (en) A cosmetic composition for skin desquamation comprising natural complex extract
KR101724529B1 (en) Cosmetic composition containing red sea cucumber extract fermented by aureobasidium pullulans
CA3210630A1 (en) Biopolymers for topical use
KR20170005534A (en) The Cosmetic composition containing the culture medium of mycelium from Elfvingia applanata using natural medium
JP2009024075A (en) Polysaccharide, method for producing the same and use of the same
JP2005001995A (en) Cosmetic
JP2002037742A (en) Skin care preparation
KR20130099277A (en) A cosmetic composition comprising hydrolysates of ecklonia cava
KR101951646B1 (en) A cosmetic composition comprising marinobacter-fermented spirulina extract for antioxydant and skin winkle improvement

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase